Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients

Nephrology

Volumn 14, Issue 5, 2009, Pages 471-475

  Eleftheriadis, Theodoros ^a   Kartsios, Charalambos ^b   Yiannaki, Efi ^b   Antoniadi, Georgia ^a   Kazila, Polizo ^c   Pliakos, Konstantinos ^a   Liakopoulos, Vassilios ^a   Markala, Dimitra ^b  

^a General District Hospital of Serres   (Greece)

^b Laboratoty of Haematology   (Greece)

^c THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

chain; Cytokines; Hemodialysis; Immune response; Inflammation; NK like T cells

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL;

ADULT; AGED; AGING; ANTIGENS, CD3; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; RENAL DIALYSIS;

EID: 68349102090     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01041.x     Document Type: Article

References (27)

1. Sarnak M, Jaber B. Mortality caused by sepsis in patients with end-stage renal disease compared with the normal population. Kidney Int. 2000 58 : 1758 64.
2. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 1999 354 : 93 9.
3. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin. Dial. 2007 20 : 440 51.
4. Gascon A, Orfao A, Lerma JL et al. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am. J. Kidney Dis. 1996 27 : 373 9.
5. Maghazachi AA. Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells. Pharmacol. Rev. 2005 57 : 339 57.
6. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kortsaris A. T-cell zeta-chain expression, phosphorylation and degradation and their role in T-cell signal transduction and immune response regulation in health and disease. Curr. Signal Transduct. Ther. 2006 1 : 191 208.
7. Baniyash M. TCR zeta-chain downregulation: Curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 2004 4 : 675 87.
8. Schindler R, Linnenweber S, Schulze M et al. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int. 1993 43 : 712 21.
9. Girndt M, Kohler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 1995 47 : 559 65.
10. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998 54 : 627 36.
11. Eleftheriadis T, Kartsios C, Yiannaki E et al. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am. J. Nephrol. 2008 28 : 152 7.
12. Eleftheriadis T, Kartsios C, Yiannaki E et al. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients. Blood Purif 2008 26 : 317 21.
13. Lanier LL, Kipps TJ, Phillips JH. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J. Exp. Med. 1985 162 : 2089 106.
14. D'Arena G, Musto P, Cascavilla N et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: Immunophenotypic features. Haematologica 1998 83 : 197 203.
15. Miyaji C, Watanabe H, Minagawa M et al. Numerical and functional characteristics of lymphocyte subsets in centenarians. J. Clin. Immunol. 1997 17 : 420 29.
16. Abedin S, Michel JJ, Lemster B, Vallejo AN. Diversity of NKR expression in aging T cells and in T cells of the aged: The new frontier into the exploration of protective immunity in the elderly. Exp. Gerontol. 2005 40 : 537 48.
17. Ogata K, Yokose N, Tamura H et al. Natural killer cells in the late decades of human life. Clin. Immunol. Immunopathol. 1997 84 : 269 75.
18. Takayama E, Koike Y, Ohkawa T et al. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells. Immunology 2003 108 : 211 19.
19. Schindler R, Lonnemann G, Schaffer J, Shaldon S, Koch KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 1994 68 : 229 33.
20. Girndt M, Heisel O, Kohler H. Influence of dialysis with polyamide vs haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol. Dial. Transplant. 1999 14 : 676 82.
21. Varela MP, Kimmel PL, Phillips TM, Mishkin GJ, Lew SQ, Bosch JP. Biocompatibility of hemodialysis membranes: Interrelations between plasma complement and cytokine levels. Blood Purif. 2001 19 : 370 79.
22. Panichi V, Migliori M, De Pietro S et al. C reactive protein in patients with chronic renal diseases. Ren. Fail. 2001 23 : 551 62.
23. Ben-Baruch A. Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators. Semin. Cancer Biol. 2006 16 : 38 52.
24. Vaknin I, Blinder L, Wang L et al. A common pathway mediated through Toll-like receptors leads to T and natural killer cell immunosuppression. Blood 2007 111 : 1437 47.
25. Kono K, Salazar-Onfray F, Petersson M et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 1996 26 : 1308 13.
26. Rodriguez PC, Zea AH, DeSalvo J et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta-chain in T lymphocytes. J. Immunol. 2003 171 : 1232 9.
27. Zea AH, Rodriguez PC, Atkins MB et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion. Cancer Res. 2005 65 : 3044 8.